Vivo Capital, which invests in healthcare companies across the US and Greater China, has amassed $1.28 billion for its ninth private equity fund from 36 investors, according to its latest regulatory filing.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
